
    
      Investigational Product GSK525762 is an orally bioavailable small molecule that is a potent
      inhibitor of the binding of BET proteins to acetylated histones. Binding of GSK525762 induces
      squamous differentiation and inhibits proliferation of patient-derived NMC cell lines both in
      culture and in murine xenografts.

      Compassionate use access to molibresib is restricted to patients with confirmed diagnosis of
      NUT Midline Carcinoma.
    
  